Back to search
FDAFDA · Food and drugs·Recall number D-0014-2026

Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05.

Published October 15, 2025 · Recall initiated: September 29, 2025

Summary

FDA records drug Class II recall D-0014-2026, published October 15, 2025 and initiated September 29, 2025. Recalling firm: Acella Pharmaceuticals, LLC; Status: Ongoing; Reported quantity: 4,680 500-count bottles; Lot: Lot #: P24ZLK1, Exp 5/31/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Acella Pharmaceuticals, LLC
Distributor
Nationwide in the USA
Lot
Lot #: P24ZLK1, Exp 5/31/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Doxycycline Hyclate Tablets, USP 100 mg*, 500-count bottle, Rx Only, Distributed by: Acella Pharmaceuticals, LLC, Alpharetta, GA 30005, NDC 42192-501-05. recalled?

Yes. FDA published recall D-0014-2026 on October 15, 2025. Reported hazard: Failed dissolution specifications: Stability testing found that the lot did not meet dissolution specifications.

What should I do if I have this product?

Voluntary: Firm initiated · Letter